Article
The recipient CXCL10 + 1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation.
Clinical immunology (Orlando, Fla.) - 1 Feb 2013
Nakata Katsuya, Takami Akiyoshi, Espinoza J Luis, Matsuo Keitaro, Morishima Yasuo, Onizuka Makoto, Fukuda Takahiro, Kodera Yoshihisa, Akiyama Hideki, Miyamura Koichi, Mori Takehiko, Nakao Shinji
Abstract excerpt
CXCL10 is a chemoattractant for immune cells that is involved in several immune-inflammatory disorders. This study retrospectively examined the impact of a single nucleotide variation (rs3921, +1642C>G) in the CXCL10 gene on transplant outcomes in a cohort of 652 patients who underwent unrelated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
